Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2020
SIETES contiene 93097 citas

 
 
 1 a 19 de 19 
Presentar resultados
Seleccionar todas
1. Cita con resumen
McEvoy JB, Daya N, Rahman F, Hoogeveen RC, Blumenthal RS, Shah AM, Ballantyne CM, Coresh J, Selvin E. Association of isolated diastolic hypertension as defined by the 2017 ACC/AHA blood pressure guideline with incident cardiovascular outcomes. JAMA 2020;323:28 de enero. [Ref.ID 103512]
2. Cita con resumen
Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016;176:238246. [Ref.ID 100117]
3.Tiene citas relacionadas Cita con resumen
Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Proton pump inhibitor use and risk of chronic kidney disease. JAMA Intern Med 2016;176:febrero. [Ref.ID 99957]
4. Cita con resumen
5.Tiene citas relacionadas
Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. The authors reply. N Engl J Med 2013;369:2459. [Ref.ID 96682]
6.Tiene citas relacionadas Cita con resumen
Shlipak MG, Mathushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369:932-43. [Ref.ID 96070]
7.Tiene citas relacionadas Cita con resumen
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghome KR, Shankar A, Smith DH, Tonelli M, Wamock DG, Wen C-P, Coresh J, Gansevoort RT, Hemmelgam BR, Levey AS, for the Chronic Kidney Disease Prognosis Consortium. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51. [Ref.ID 92860]
8. Cita con resumen
DeMarco MAM, Maynard JW, Baer AN, Gelber AC, Young JH, Alonso A, Coresh J. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: The Atherosclerosis Risk in Communities cohort study. Arthritis & Rheumatism 2012;64:121. [Ref.ID 92602]
9. Cita con resumen
Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11. [Ref.ID 87957]
10. Cita con resumen
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro III AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, +, Greene T, Coresh J, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12. [Ref.ID 85873]
11.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47. [Ref.ID 81584]
12. Cita con resumen
Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007;297:1455-64. [Ref.ID 79788]
13.
Rahman M, Brown CD, Coresh J, Davis BR, Eckfeldt JH, Kopyt N, Levey AS, Nwachuku C, Pressel S, Reisin E, Walworth C, for the ALLHAT Collaborative Research Group. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease. A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Arch Intern Med 2004;164:969-76. [Ref.ID 70061]
14.
Levey AS, Coresh J, Balk E, Kausz A T, Levin A, Steffes MW, Hogg RJ, Perrone R D, Lau J, Eknoyan G. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47. [Ref.ID 66885]
15.Tiene citas relacionadas Cita con resumen
Thiermann DR, Coresh J, Schulman SP, Gerstenblith G, Powe N R. Thrombolytic therapy and mortality. Lancet 2001;357:1367. [Ref.ID 56432]
16.Tiene citas relacionadas
Thiemann DR, Coresh J, Powe N R. Quality of care at teaching and nonteaching hospitals. JAMA 2000;284:2994-5. [Ref.ID 54445]
17.
Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco L E, Hendrix CW, Flexner C. The effects of rifampicin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clin Pharmacol Ther 1999;65:428-38. [Ref.ID 44610]
18.
Daumit GL, Hermann JA, Coresh J, Powe N R. Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease. Ann Intern Med 1999;130:173-82. [Ref.ID 42857]
Seleccionar todas
 
 1 a 19 de 19